Travel and tourism companies were among those leading local gainers.
Genesis Energy launched its rights offering as sentiment soured.
Ryman slides as Forsyth Barr trims its price target.
USX-listed company, trading as Waitaki Biosciences, has been exploring capital raising avenues due to a working capital deficit.
Bremworth is finding there are still some believers in wool.
The boss of the listed jeweller says the company has been ‘more homogenous’ than it needed to be in the past.
The Commerce Commission is reviewing whether a deal to sell Bremworth to the owners of Godfrey Hirst will dampen competition in the New Zealand flooring market.
Vista shone in a flurry of earnings in February’s last trading.
Gareth Edgecombe is hopeful the market could become a material part of its portfolio.
Issue that led to failure has been identified and rectified, but fabrication of new tank will push timeline, says Sir Peter Beck.